Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Non-Current Assets (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Non-Current Assets for 9 consecutive years, with $4.9 billion as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 639.08% year-over-year to $4.9 billion; the TTM value through Mar 2026 reached $13.3 billion, up 1301.14%, while the annual FY2025 figure was $573.8 million, 9.83% up from the prior year.
  • Non-Current Assets hit $4.9 billion in Q1 2026 for Select Medical Holdings, up from $573.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $6.4 billion in Q3 2023 and bottomed at -$1.2 billion in Q3 2024.
  • Average Non-Current Assets over 5 years is $3.1 billion, with a median of $4.7 billion recorded in 2025.
  • On a YoY basis, Non-Current Assets climbed as much as 3870.05% in 2025 and fell as far as 178.25% in 2025.
  • Select Medical Holdings' Non-Current Assets stood at $381.5 million in 2022, then skyrocketed by 37.28% to $523.8 million in 2023, then fell by 0.26% to $522.4 million in 2024, then increased by 9.83% to $573.8 million in 2025, then surged by 759.23% to $4.9 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $4.9 billion, $573.8 million, and $4.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.